Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited)

v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Revenues:        
License and collaborative fees $ 430 $ 645 $ 3,196 $ 1,852
Contract and other 205 1,429 1,844 5,412
Total revenues 635 2,074 5,040 7,264
Operating expenses:        
Research and development 8,674 17,559 35,986 57,255
Selling, general and administrative 4,053 5,632 13,138 15,913
Restructuring   2,561 15 2,561
Total operating expenses 12,727 25,752 49,139 75,729
Loss from operations (12,092) (23,678) (44,099) (68,465)
Other income (expense):        
Interest expense (982) (1,030) (2,991) (3,152)
Other income (expense), net 289 (194) 585 1,453
Revaluation of contingent warrant liabilities 260 24,422 10,455 24,206
Net loss and comprehensive loss $ (12,525) $ (480) $ (36,050) $ (45,958)
Basic and diluted net loss per share of common stock $ (2.08) $ (0.08) $ (6.00) $ (7.83)
Shares used in computing basic and diluted net loss per share of common stock 6,029 5,928 6,010 5,872